This client is a market leading, fully integrated drug delivery/specialty pharmaceutical company. It has development in-house improved forms of well-established compounds. The company is looking to further strengthen its franchise with major pharmaceutical companies by offering Diffucaps® Sodium Diclofenac SR capsules.

Company licensing deals usually include licensing fees and royalty income on the net sales of the specialty and manufacturing revenues.

The company licenses the right to customers to register and market the specialty in the territory. The company provides potential licences with all the support needed in the pre and post launch phases of the product i.e regulatory, manufacturing, technical, commercial…